Here's why I think the Sonic Healthcare share price could jump higher

Increasing COVID-19 testing in this third wave of Omicron could lead to resurgent earnings.

| More on:
Medical technicians wearing white medical coats conduct a test in a laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic Healthcare is a key player in the COVID testing space
  • Another wave has started in Australia, which could lead to more testing
  • Sonic Healthcare can use its elevated profit to make acquisitions and return cash to shareholders

The Sonic Healthcare Limited (ASX: SHL) share price could be a leading opportunity right now, in my opinion.

Sonic Healthcare is one of the leading global pathology businesses, with operations in Australia, New Zealand, North America, and Europe.

Since the start of 2022, the Sonic Healthcare share price has dropped back by 27%. I think the business looks good value with what's going on in the healthcare space.

Third wave of Omicron to lead to more testing?

Over the past two and a half years, COVID testing has helped the company's revenue and net profit after tax (NPAT) significantly.

According to Sonic's FY22 half-year result, its revenue increased 7% year over year to $4.76 billion. Net profit went up 22% to $828 million. But, the base revenue (which excludes COVID revenue) increased 4.3% year over year.

Over the FY22 first half, the Sonic Healthcare share price increased by 22.5%.

Sonic management is expecting ongoing growth of the base business, with "strong underlying drivers, including catch-up of testing postponed through pandemic".

COVID-19 cases are now increasing, as are hospitalisations, as a third wave of Omicron sweeps across Australia.

The federal chief health officer, Paul Kelly, has warned this is the "start of this wave, not the end", according to reporting by The Guardian.

Calls to get a PCR test despite a negative RAT

Concession card holders will now have continued access to free RAT tests through their local pharmacies. The program has been extended until 31 July.

Australian Medical Association vice president Dr Chris Moy said people who return a negative RAT test but continue to experience symptoms should have a PCR test.

Moy told ABC Radio Sydney:

A positive is a positive. The issue is you can't rely on a negative if you continue to have symptoms… By the time [a RAT] may go positive, it may be too late to get these antivirals.

We need you to go out there straight away, get a PCR test. If you're positive then we can get the ball rolling to give you these potentially life-saving treatments.

I think these different factors could lead to a resurgence of PCR testing, which would be a boost for Sonic's earnings and therefore, potentially, the Sonic Healthcare share price.

Even after this wave, I think Sonic's previous comments about expectations of ongoing COVID testing are almost as relevant now as they were with the FY22 half-year result:

[We] expect a sustainable level of COVID testing into the future, including routine COVID testing, screening programs, variant testing, whole genome sequencing, antibody tests.

Profit can be used to boost shareholder returns

I like that Sonic Healthcare has been using some of its elevated cash flow to make acquisitions to boost long-term growth.

For example, over the past 12 months it has bought ProPath in Dallas. ProPath makes US$110 million in revenue. It's also bought Canberra Imaging Group in Australia, which makes $60 million in revenue.

It could continue to make earnings-boosting acquisitions, too.

Sonic Healthcare has a progressive dividend policy. It has also launched a $500 million on-market share buyback.

Foolish takeaway

I think that the Sonic Healthcare share price is attractive because of the ongoing growth of its base business, the ageing demographic tailwinds, continuing COVID-19 testing, a growing dividend, and the ability for the business to keep putting excess cash to good use with acquisitions and share buybacks.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Close-up of a business man's hand stacking gold coins into piles on a desktop.
Opinions

If I had a big cash pile like Warren Buffett, here's how I'd spend it in 2025

I'd put Buffett's billions to work straight away.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Opinions

Why I'm bullish on the Guzman Y Gomez share price for the long-term

The business is delivering spicy growth.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

2 ASX shares I'd buy if the ASX crashes again

I think the best opportunities can be found when the market falls.

Read more »

A man and woman sit at a desk staring intently at a laptop screen with papers next to them.
Opinions

Where I'd invest $5,000 in ASX 300 shares right now

These stocks look like excellent investments today.

Read more »

Man smiling at a laptop because of a rising share price.
Opinions

My 2 favourite ASX sectors to invest in

Finding your groove can help your investing success.

Read more »

Legendary share market investing expert and owner of Berkshire Hathaway Warren Buffett
Opinions

3 things I learned from Warren Buffett being the CEO of Berkshire Hathaway

The Oracle from Omaha is in his last year as CEO.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Opinions

Why I think this small ASX dividend share is a great buy today

This small business offers a lot of what I like for passive income.

Read more »

A corporate man crosses his arms to make an X, indicating no deal.
Opinions

How to invest: my 3 biggest ASX share dealbreakers

I want to avoid certain things with my investing.

Read more »